Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
2002 1
2004 1
2005 3
2007 1
2008 1
2009 3
2010 3
2011 2
2012 5
2013 7
2014 8
2015 6
2016 9
2017 5
2018 4
2019 3
2020 5
2021 9
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).
Peters S, Gettinger S, Johnson ML, Jänne PA, Garassino MC, Christoph D, Toh CK, Rizvi NA, Chaft JE, Carcereny Costa E, Patel JD, Chow LQM, Koczywas M, Ho C, Früh M, van den Heuvel M, Rothenstein J, Reck M, Paz-Ares L, Shepherd FA, Kurata T, Li Z, Qiu J, Kowanetz M, Mocci S, Shankar G, Sandler A, Felip E. Peters S, et al. Among authors: christoph d. J Clin Oncol. 2017 Aug 20;35(24):2781-2789. doi: 10.1200/JCO.2016.71.9476. Epub 2017 Jun 13. J Clin Oncol. 2017. PMID: 28609226 Free PMC article. Clinical Trial.
Contrast enhanced ultrasound of sentinel lymph nodes.
Cui X, Ignee A, Nielsen MB, Schreiber-Dietrich D, De Molo C, Pirri C, Jedrzejczyk M, Christoph DF. Cui X, et al. Among authors: christoph df. J Ultrason. 2013 Mar;13(52):73-81. doi: 10.15557/JoU.2013.0006. Epub 2013 Mar 30. J Ultrason. 2013. PMID: 26675994 Free PMC article. Review.
First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up.
Jia Z, Wang Y, Cao L, Wang Y, Song Y, Yang X, Bing Z, Cao Z, Liu P, Zhang S, Chen Z, Huang M, Yu Y, Han-Zhang H, Song J, Christoph DC, Passaro A, Gridelli C, Hishida T, Liang N, Li S. Jia Z, et al. Among authors: christoph dc. J Thorac Dis. 2020 Jul;12(7):3764-3773. doi: 10.21037/jtd-20-1882. J Thorac Dis. 2020. PMID: 32802455 Free PMC article. Review. No abstract available.
Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma.
Ferdinandus J, Barbato F, Chodyla M, Fendler WP, Kessler L, Pomykala KL, Metzenmacher M, Krefting F, Hager T, Umutlu L, Herrmann K, Christoph DC. Ferdinandus J, et al. Among authors: christoph dc. J Nucl Med. 2021 Feb;62(2):191-194. doi: 10.2967/jnumed.120.245803. Epub 2020 Jun 12. J Nucl Med. 2021. PMID: 32532926
72 results